Literature DB >> 10117966

Psychosocial development of children with hemangiomas: home, school, health care collaboration.

C A Dieterich-Miller1, P L Safford.   

Abstract

Hemangiomas are among the most common neoplasms of childhood and often found on the face, head, and neck. In a society that places great importance on physical appearance, sustaining a hemangioma can significantly influence the psychosocial development of children. The purpose of this article is to briefly discuss the etiology of hemangiomas and provide practical suggestions for educators, health care professionals, and parents to foster the psychosocial development of children with a hemangioma.

Entities:  

Mesh:

Year:  1992        PMID: 10117966     DOI: 10.1207/s15326888chc2102_3

Source DB:  PubMed          Journal:  Child Health Care        ISSN: 0273-9615


  4 in total

1.  Development and Validation of a Quality-of-Life Instrument for Infantile Hemangiomas.

Authors:  Sarah L Chamlin; Anthony J Mancini; Jin-Shei Lai; Jennifer L Beaumont; David Cella; Denise Adams; Beth Drolet; Eulalia Baselga; Ilona J Frieden; Maria Garzon; Kristin Holland; Kimberly A Horii; Anne W Lucky; Catherine McCuaig; Denise Metry; Kimberly D Morel; Brandon D Newell; Amy J Nopper; Julie Powell; Dawn Siegel; Anita N Haggstrom
Journal:  J Invest Dermatol       Date:  2015-01-23       Impact factor: 8.551

2.  Development and validation of psychological status questionnaire for parents of infantile hemangiomas.

Authors:  Wei Peng; Haijin Liu; Jincai Chen; Yanan Zheng; Xianyun Xu; Hong Tang; Qian Liu
Journal:  Transl Pediatr       Date:  2021-12

Review 3.  The impact of pediatric skin disease on self-esteem.

Authors:  K L Vivar; L Kruse
Journal:  Int J Womens Dermatol       Date:  2017-12-12

Review 4.  Propranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapy.

Authors:  Andreas Fette
Journal:  ScientificWorldJournal       Date:  2013-05-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.